Retraction
microRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target
Paper Information
Record ID:
26234
Author(s):
Journal:
Publication Date:
April 02, 2014
Retraction Date:
February 26, 2021
(4.7 years years ago)
Subjects:
Specific Fields:
Biology - Cancer Biology - Cellular Genetics Medicine - Internal Medicine - Oncology
Biology - Cancer Biology - Cellular Genetics Medicine - Internal Medicine - Oncology
Country:
🇹🇼 TaiwanArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (74)
74
Total Citations8
Post-Retraction(10.8%)
65
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
0
Within 30 days
7
Within 1 year
1
After 2+ years
1374
Days since retraction (latest)
Bioinformatics and Experimental Insights Into <scp>miR</scp>‐182, hsa_circ_0070269, and circ‐102,166 as Therapeutic Targets for <scp>HCV</scp>‐Associated <scp>HCC</scp>
Yasmeen Ishaq, Bisma Rauff, Badr Alzahrani et al. (7 authors)
Cancer Reports
Published: Dec 2024
1374 days after retraction
Potential plasma biomarkers: miRNA-29c, miRNA-21, and miRNA-155 in clinical progression of Hepatocellular Carcinoma patients
Neneng Ratnasari, Puji Lestari, Dede Renovaldi et al. (14 authors)
PLoS ONE
Open Access
Published: Feb 2022
40 citations
40 citations
353 days after retraction
Prevention and Treatment of Hepatocellular Carcinoma Using miRNAs
Zahra Farzaneh, Maryam Farzaneh
Archives of Iranian Medicine
Open Access
Published: Feb 2022
7 citations
7 citations
340 days after retraction
Non‐coding RNA‐associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma
Sattar Khashkhashi-Moghadam, Babak Bakhshinejad, Ali Khalafizadeh et al. (5 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Dec 2021
23 citations
23 citations
291 days after retraction
miR-30d-5p represses the proliferation, migration, and invasion of lung squamous cell carcinoma via targeting <i>DBF4</i>
Yitian Qi, Yi Hou, Liangchen Qi
Journal of Environmental Science and Health Part C
Published: Jun 2021
13 citations
13 citations
118 days after retraction
[Retracted] MicroRNA‑133a inhibits proliferation and invasion, and induces apoptosis in gastric carcinoma cells via targeting fascin actin‑bundling protein 1
Lai Chen, Zihua Chen, Ruixin Li
Molecular Medicine Reports
Open Access
Published: Jun 2021
14 citations
14 citations
95 days after retraction
Epigenomics in Hurthle Cell Neoplasms: Filling in the Gaps Towards Clinical Application
Şule Canberk, Ana Rita Lima, Mafalda Pinto et al. (5 authors)
Frontiers in Endocrinology
Open Access
Published: May 2021
5 citations
5 citations
87 days after retraction
Shikonin treatment ameliorates Lipopolysaccharides (LPS) induced acute liver failure in mice via regulating the miR-106/MCL1 and miR-34a/SIRT1/TP53 signaling
Fan Huang, Hua Hai, Buwei Gao
Archives of Medical Science
Open Access
Published: May 2021
72 days after retraction
Retracted: microRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target
BioMed Research International
BioMed Research International
Open Access
Published: Feb 2021
Same day as retraction
Expression of MicroRNA-155 in Hepatitis B Virus-Related to Hepatocellular Carcinoma
Dede Renovaldi, Juwita Radityaningsih, Puji Lestari et al. (7 authors)
Advances in health sciences research/Advances in Health Sciences Research
Open Access
Published: Jan 2021
1 citation
1 citation
56 days before retraction
Anti-Micro RNA-221 a Promising Genetic Therapy of Oral Squamous Cell Carcinoma (SCC-25)
Shaimaa Ali Hamouda Ali El Basuony, Reham Hamed
Brazilian Dental Journal
Open Access
Published: Nov 2020
6 citations
6 citations
117 days before retraction
Development of a novel panel based on micro-RNAs (21, 29a, 200 and 335) and alpha-fetoprotein as diagnostic biomarkers for hepatocellular carcinoma associated with hepatitis C infection
Manar S. Fouda, Mohamed M. Omran, Gehad Tarek et al. (4 authors)
Arab Journal of Gastroenterology
Published: Oct 2020
13 citations
13 citations
126 days before retraction
<i>MicroRNA-587</i> Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting Ribosomal Protein SA
Miao Chen, Duo Wang, Junjie Liu et al. (8 authors)
BioMed Research International
Open Access
Published: Sep 2020
9 citations
9 citations
172 days before retraction
Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma
Asahiro Morishita, Koji Fujita, Hisakazu Iwama et al. (20 authors)
AJP Gastrointestinal and Liver Physiology
Open Access
Published: Jan 2020
34 citations
34 citations
417 days before retraction
miR-223-3p regulating the occurrence and development of liver cancer cells by targeting FAT1 gene
Jun Xu, Bei Wang, Zheng-tao Liu et al. (6 authors)
Mathematical Biosciences & Engineering
Open Access
Published: Dec 2019
15 citations
15 citations
451 days before retraction
Potential of epigenetic events in human thyroid cancer
Abdelkareem A. Ahmed, Mohammed Elmujtba Adam Essa
Cancer Genetics
Published: Aug 2019
23 citations
23 citations
553 days before retraction
Integrated mRNA‐Seq and miRNA‐Seq analysis of PLCγ2‐overexpressing hepatocarcinoma cells and identification of the associated miRNA‐mRNA network
Xiaoguang Chen, Xuemin Zhu, Zhiguo Wei et al. (4 authors)
Journal of Cellular Biochemistry
Published: Jul 2019
5 citations
5 citations
591 days before retraction
Long intergenic noncoding RNA SNHG16 interacts with miR-195 to promote proliferation, invasion and tumorigenesis in hepatocellular carcinoma
Xuhua Xie, Xiaopei Xu, Changyu Sun et al. (4 authors)
Experimental Cell Research
Published: Jul 2019
38 citations
38 citations
595 days before retraction
Artificial Neural Network With Composite Architectures for Prediction of Local Control in Radiotherapy
Sunan Cui, Yi Luo, H. Eric Tseng et al. (5 authors)
IEEE Transactions on Radiation and Plasma Medical Sciences
Open Access
Published: Nov 2018
22 citations
22 citations
820 days before retraction
Prognostic role of miR‑760 in hepatocellular carcinoma
Dong Sun, Jinghui Lu, Chunxiao Hu et al. (7 authors)
Oncology Letters
Open Access
Published: Oct 2018
12 citations
12 citations
877 days before retraction
circFBLIM1 act as a ceRNA to promote hepatocellular cancer progression by sponging miR-346
Ning Bai, Eming Peng, Xingsheng Qiu et al. (8 authors)
Journal of Experimental & Clinical Cancer Research
Open Access
Published: Jul 2018
149 citations
149 citations
946 days before retraction
BINDING OF 3H-DMBA WITH BIOPOLYMERS OF MOTHER AND FETUS TISSUES IN RATS DURING TRANSPLACENTAL CARCINOGENESIS
Sergey M. Ivanov, V A Aleksandrov, Aleksandr V. Semenov et al. (4 authors)
Voprosy Onkologii
Open Access
Published: May 2018
1032 days before retraction
Tissue miRNA 483-3p expression predicts tumor recurrence after surgical resection in histologically advanced hepatocellular carcinomas
Francesco Vasuri, Silvia Fittipaldi, Vanessa De Pace et al. (10 authors)
Oncotarget
Open Access
Published: Apr 2018
9 citations
9 citations
1061 days before retraction
MicroRNA profile in HBV-induced infection and hepatocellular carcinoma
Guanyu Wang, Fulu Dong, Zhiyao Xu et al. (9 authors)
BMC Cancer
Open Access
Published: Dec 2017
81 citations
81 citations
1183 days before retraction
A Review of Physical Activity and Circulating miRNA Expression: Implications in Cancer Risk and Progression
Suzanne Dufresne, Amélie Rébillard, Paola Muti et al. (5 authors)
Cancer Epidemiology Biomarkers & Prevention
Open Access
Published: Nov 2017
57 citations
57 citations
1199 days before retraction
Targeted delivery of microRNA‐199a‐3p using self‐assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice
Aditi Varshney, Jiban Jyoti Panda, Avishek Singh et al. (8 authors)
Hepatology
Published: Nov 2017
67 citations
67 citations
1208 days before retraction
Nanomedicines: a theranostic approach for hepatocellular carcinoma
Afreen Usmani, Anuradha Mishra, Mohd Ahmad
Artificial Cells Nanomedicine and Biotechnology
Open Access
Published: Sep 2017
48 citations
48 citations
1267 days before retraction
miR-663 promotes NPC cell proliferation by directly targeting CDKN2A
Shaoqiang Liang, Ning Zhang, Yanming Deng et al. (10 authors)
Molecular Medicine Reports
Open Access
Published: Aug 2017
25 citations
25 citations
1305 days before retraction
The noncoding RNA HOXD-AS1 is a critical regulator of the metastasis and apoptosis phenotype in human hepatocellular carcinoma
Shan Lu, Jian-Sheng Zhou, Yimin Sun et al. (7 authors)
Molecular Cancer
Open Access
Published: Jul 2017
86 citations
86 citations
1318 days before retraction
Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma
Vikrant Rai, Joe Abdo, Abdullah Alsuwaidan et al. (6 authors)
Molecular and Cellular Biochemistry
Published: Jun 2017
38 citations
38 citations
1360 days before retraction
Prognostic microRNAs in upper tract urothelial carcinoma: multicenter and international validation study
Laura Izquierdo, Ruth Montalbo, Mercedes Ingelmo‐Torres et al. (13 authors)
Oncotarget
Open Access
Published: May 2017
12 citations
12 citations
1382 days before retraction
miR-133a acts as a tumor suppressor in colorectal cancer by targeting eIF4A1
Wenfeng Li, Anqi Chen, Lingling Xiong et al. (10 authors)
Tumor Biology
Open Access
Published: May 2017
43 citations
43 citations
1397 days before retraction
miR-493-5p suppresses hepatocellular carcinoma cell proliferation through targeting GP73
Jinli Zhao, Tongsheng Xu, Rui Wang et al. (5 authors)
Biomedicine & Pharmacotherapy
Published: Apr 2017
37 citations
37 citations
1413 days before retraction
Anti-microRNA-21/221 and microRNA-199a transfected by ultrasound microbubbles induces the apoptosis of human hepatoma HepG2 cells
Xinmin Guo, Shunhua Guo, Liwen Pan et al. (6 authors)
Oncology Letters
Open Access
Published: Mar 2017
14 citations
14 citations
1435 days before retraction
miR-195 inhibits cell proliferation via targeting AEG-1 in hepatocellular carcinoma
Jingjun Yan, Ying Chang, Yu‐Nan Zhang et al. (6 authors)
Oncology Letters
Open Access
Published: Mar 2017
35 citations
35 citations
1451 days before retraction
MicroRNA31-NDRG3 regulation axes are essential for hepatocellular carcinoma survival and drug resistance
Zhonghai Du, Shuxian Niu, Xiaoyu Xu et al. (4 authors)
Cancer Biomarkers
Published: Mar 2017
33 citations
33 citations
1453 days before retraction
The miR-383-LDHA axis regulates cell proliferation, invasion and glycolysis in hepatocellular cancer.
Zhixiong Fang, Langqiu He, Hui Jia et al. (6 authors)
PubMed
Published: Feb 2017
41 citations
41 citations
1486 days before retraction
Hypoxia-induced hsa-miR-101 promotes glycolysis by targeting TIGAR mRNA in clear cell renal cell carcinoma
Xiaochao Xu, Chao Liu, Jinku Bao
Molecular Medicine Reports
Open Access
Published: Jan 2017
21 citations
21 citations
1494 days before retraction
MicroRNA-133a Inhibits Proliferation of Gastric Cancer Cells by Downregulating ERBB2 Expression
Chang Li, Xiaoping Li, Shuohui Gao et al. (5 authors)
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Open Access
Published: Jan 2017
21 citations
21 citations
1497 days before retraction
High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection
Johann von Felden, Denise Heim, Kornelius Schulze et al. (8 authors)
BMC Cancer
Open Access
Published: Jan 2017
26 citations
26 citations
1500 days before retraction
Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison
Sijia Shen, Yuxin Lin, Xuye Yuan et al. (8 authors)
Scientific Reports
Open Access
Published: Dec 2016
79 citations
79 citations
1544 days before retraction
Short-term and long-term efficacy of 7 targeted therapies for the treatment of advanced hepatocellular carcinoma
Meng Niu, Duo Hong, Tengchuang Ma et al. (7 authors)
Medicine
Open Access
Published: Dec 2016
14 citations
14 citations
1548 days before retraction
miR-1297 promotes cell proliferation by inhibiting RB1 in liver cancer
Chengyong Liu, Chunying Wang, Ji Wang et al. (4 authors)
Oncology Letters
Open Access
Published: Oct 2016
25 citations
25 citations
1579 days before retraction
Growth Regulation in Hepatobiliary Cancer: Epigenetic Mechanisms
Arthur Zimmermann
Springer eBooks
Published: Oct 2016
1590 days before retraction
Etiology and Pathogenesis of Hepatocellular Carcinoma: Epigenetic Mechanisms
Arthur Zimmermann
Springer eBooks
Published: Oct 2016
1590 days before retraction
MicroRNA‐21 in laryngeal squamous cell carcinoma: Diagnostic and prognostic features
Evren Erkul, İsmail Yılmaz, Atila Güngör et al. (5 authors)
The Laryngoscope
Published: Aug 2016
15 citations
15 citations
1649 days before retraction
miR-26b enhances radiosensitivity of hepatocellular carcinoma cells by targeting EphA2.
Qiao Jin, Xiang Jun Li, Pei Cao
PubMed
Published: Aug 2016
14 citations
14 citations
1670 days before retraction
Efficacy of serum miR-106b and miR-222 as non-invasive diagnostic markers for hepatocellular carcinoma in HCV-infected Egyptian patients
Azza Atef, Abdel-Hady Abdel-Wahab, Emad Ahmed et al. (4 authors)
Deleted Journal
Open Access
Published: Jul 2016
1 citation
1 citation
1701 days before retraction
MiR-503 inhibits hepatocellular carcinoma cell growth via inhibition of insulin-like growth factor 1 receptor
Liansheng Gong, Qinggang Tian, Jiantai He et al. (6 authors)
OncoTargets and Therapy
Open Access
Published: Jun 2016
22 citations
22 citations
1731 days before retraction
The altered microRNA profile in andrographolide-induced inhibition of hepatoma tumor growth
Bin Lü, Yuchen Sheng, Jiaqi Zhang et al. (5 authors)
Gene
Published: May 2016
25 citations
25 citations
1751 days before retraction
Quick Stats
Total Citations:
74
Years Since Retraction:
4.7 years
Open Access:
Yes
Last Checked:
Jul 24, 2025